RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early test of new drug for Tough-to-Treat blood cancer halted
Disease control TerminatedThis was an early-stage study to find a safe and effective dose of an experimental drug called AMG 420 for people with multiple myeloma that had returned or stopped responding to at least three prior types of therapy. The trial involved 23 participants who received the drug throu…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New pill tested for Tough-to-Treat blood cancer
Disease control TerminatedThis study tested a new oral drug called Narazaciclib, given with a steroid (dexamethasone), for people with multiple myeloma that has come back or stopped responding to standard treatments. The main goals were to find a safe dose and see if the combination could help control the…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Adriana Rossi • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC